Advanced Lung Cancer Treatment With Metformin and Chemo-Radiotherapy

NCT02115464 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

54

Enrollment

OTHER

Sponsor class

Stopped The accrual rate was not high enough to reach the target sample size.

Conditions

Lung Cancer

Interventions

DRUG: Metformin plus Chemo-radiotherapy
RADIATION: Chemo-radiotherapy

Sponsor

Ontario Clinical Oncology Group (OCOG)

Collaborators

[object Object]